Partnered products

4SC has out-licensed and partnered drug candidates to several national and international pharma and biotech companies.

Sold to Immunic Inc.

IMU-838 is an orally available, next-generation, small molecule inhibitor of dihydroorotate dehydrogenase (DHODH) which plays a key role in the metabolism of activated T and B cells while leaving other immune cells largely unaffected.

Share this page:

Follow us on: